News
![takedalogo](https://pharmaphorum.com/wp-content/uploads/2017/01/TakedaLogo.jpg)
Takeda bags Japanese approval for Crohn's cell therapy Alofi...
Takeda has chalked up another milestone for its Alofisel cell therapy for a complication of Crohn's disease, becoming the first allogeneic stem cell therapy to be approved in Japan.